Matrix metalloproteinase-3 removes agrin from synaptic basal lamina

被引:0
作者
VanSaun, M [1 ]
Werle, MJ [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA
来源
JOURNAL OF NEUROBIOLOGY | 2000年 / 43卷 / 02期
关键词
agrin; matrix metalloproteinase-3; neuromuscular junction; Schwann cell; synapse elimination;
D O I
10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.3.CO;2-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Agrin, a heparin sulfate proteoglycan. is an integral member of the synaptic basal lamina and plays a critical role in the formation and maintenance of the neuromuscular junction, The N-terminal region of agrin binds tightly to basal lamina, while the C-terminal region interacts with a muscle-specific tyrosine kinase (MuSK) to induce the formation of the postsynaptic apparatus. Although the binding of agrin to basal lamina is tight, the binding of agrin to MuSK has yet to be shown; therefore, basal lamina binding is critical for maintaining the presentation of agrin to MuSK, Here we report evidence that supports our hypothesis that matrix metalloproteinase-3 (MMP-3) is responsible for the removal of agrin from synaptic basal lamina. Antibodies to the hinge region of human MMP-3 recognize molecules concentrated at the frog neuromuscular junction in both cross sections and whole mounts, Electron microscopy of neuromuscular junctions stained with antibodies to MMP-3 reveals that staining is found in the extracellular matrix surrounding the Schwann cell. Treatment of sections from frog anterior tibialis muscle with MMP-3 results in a clear and reproducible removal of agrin immunoreactivity from synaptic basal lamina. The same MMP-3 treatment does not alter antilaminin staining. These results support our hypothesis that synaptic activity results in the activation of MMP-3 at the neuromuscular junction and that MMP-3 specifically removes agrin from synaptic basal lamina. (C) 2000 John Wiley & Sons, Inc. J Neurobiol 43: 140-149. 2000.
引用
收藏
页码:140 / 149
页数:10
相关论文
共 32 条
[1]   ISOFORMS OF AGRIN ARE WIDELY EXPRESSED IN THE DEVELOPING RAT AND MAY FUNCTION AS PROTEASE INHIBITORS [J].
BIROC, SL ;
PAYAN, DG ;
FISHER, JM .
DEVELOPMENTAL BRAIN RESEARCH, 1993, 75 (01) :119-129
[2]   Matrix metalloproteinase inhibitors [J].
Brown, PD .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :125-136
[3]   ACETYLCHOLINE RECEPTORS IN REGENERATING MUSCLE ACCUMULATE AT ORIGINAL SYNAPTIC SITES IN THE ABSENCE OF THE NERVE [J].
BURDEN, SJ ;
SARGENT, PB ;
MCMAHAN, UJ .
JOURNAL OF CELL BIOLOGY, 1979, 82 (02) :412-425
[4]   Alternatively spliced isoforms of nerve- and muscle-derived agrin: Their roles at the neuromuscular junction [J].
Burgess, RW ;
Nguyen, QT ;
Son, YJ ;
Lichtman, JW ;
Sanes, JR .
NEURON, 1999, 23 (01) :33-44
[5]   EFFECT OF LOW CALCIUM AND PROTEASE INHIBITORS ON SYNAPSE ELIMINATION DURING POSTNATAL-DEVELOPMENT IN THE RAT SOLEUS MUSCLE [J].
CONNOLD, AL ;
EVERS, JV ;
VRBOVA, G .
DEVELOPMENTAL BRAIN RESEARCH, 1986, 28 (01) :99-107
[6]  
Culican SM, 1998, J NEUROSCI, V18, P4953
[7]   The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo [J].
DeChiara, TM ;
Bowen, DC ;
Valenzuela, DM ;
Simmons, MV ;
Poueymirou, WT ;
Thomas, S ;
Kinetz, E ;
Compton, DL ;
Rojas, E ;
Park, JS ;
Smith, C ;
DiStefano, PS ;
Glass, DJ ;
Burden, SJ ;
Yancopoulos, GD .
CELL, 1996, 85 (04) :501-512
[8]   Electron microscopic structure of agrin and mapping of its binding site in laminin-1 [J].
Denzer, AJ ;
Schulthess, T ;
Fauser, C ;
Schumacher, B ;
Kammerer, RA ;
Engel, J ;
Ruegg, MA .
EMBO JOURNAL, 1998, 17 (02) :335-343
[9]   PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN THE NEUROMUSCULAR SYSTEM .1. DEVELOPMENTAL REGULATION OF PLASMINOGEN-ACTIVATOR ISOFORMS DURING INVITRO MYOGENESIS IN 2 CELL-LINES [J].
FESTOFF, BW ;
RAO, JS ;
MABEN, C ;
HANTAI, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 144 (02) :262-271
[10]   Defective neuromuscular synaptogenesis in agrin-deficient mutant mice [J].
Gautam, M ;
Noakes, PG ;
Moscoso, L ;
Rupp, F ;
Scheller, RH ;
Merlie, JP ;
Sanes, JR .
CELL, 1996, 85 (04) :525-535